Kameda-Smith, Michelle M.
Zhu, Helen
Luo, En-Ching
Suk, Yujin http://orcid.org/0000-0002-3966-3771
Xella, Agata
Yee, Brian http://orcid.org/0000-0001-5615-8550
Chokshi, Chirayu
Xing, Sansi
Tan, Frederick
Fox, Raymond G.
Adile, Ashley A.
Bakhshinyan, David
Brown, Kevin http://orcid.org/0000-0002-5514-2538
Gwynne, William D.
Subapanditha, Minomi
Miletic, Petar
Picard, Daniel http://orcid.org/0000-0003-3375-6202
Burns, Ian
Moffat, Jason http://orcid.org/0000-0002-5663-8586
Paruch, Kamil
Fleming, Adam http://orcid.org/0000-0002-7194-3220
Hope, Kristin
Provias, John P.
Remke, Marc http://orcid.org/0000-0002-9404-9993
Lu, Yu
Reya, Tannishtha http://orcid.org/0000-0002-5956-8536
Venugopal, Chitra
Reimand, Jüri http://orcid.org/0000-0002-2299-2309
Wechsler-Reya, Robert J. http://orcid.org/0000-0002-7463-8352
Yeo, Gene W. http://orcid.org/0000-0002-0799-6037
Singh, Sheila K. http://orcid.org/0000-0003-1272-5300
Article History
Received: 21 May 2021
Accepted: 18 November 2022
First Online: 6 December 2022
Change Date: 10 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-35816-6
Competing interests
: S.K.S. is a scientific advisor for Century Therapeutics Inc. Her role in the company has been reviewed and is supported by McMaster University. G.W.Y. is co-founder and member of the Board of Directors, on the SAB, equity holder, and paid consultant for Eclipse BioInnovations. T.R. is a founder, member of the Board of Directors and holds executive roles at Tiger Hill Therapeutics. The authors declare no other competing interests.